Takeda Pharmaceutical Co Ltd ADR (Sponsored)

(TKPYY)

By |

Profile

Takeda is Japan's largest pharmaceutical company, with annual revenue around $16 billion and a focus on four therapeutic areas: oncology, gastroenterology, vaccines, and neurology. Roughly 40% of its revenue comes from Japan. The Millennium acquisition (2008) brought rights to Velcade, Ninlaro, and Entyvio. The Nycomed acquisition (2011) expanded Takeda's exposure to Europe and emerging markets. Other notable products include Azilva (blood pressure), leuprorelin (prostate cancer), and Trintellix (depression).

Contact Information

Website: www.takeda.co.jp
Email: takeda.ir.contact@takeda.com
Main Phone: +81 662042111
Address: 4-1-1 Doshomachi
Address 2: Chuo-ku
City / Town: Osaka
Country: JPN
Postal Code: 540-8645

Issuer Information

Exchange: OTO
Employees: 27230
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 17.17 $ -0.27 (-1.55%)
Last Price 17.17 Change $ -0.27 Change % -1.55 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 17.43 High 17.78 Low 17.12 Prev Close 17.44
Last Trade Volume 7.5 mi 52 Wk Hi 31.29 52 Wk Low 16.03
Market Cap 26.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,562,645,790.00 EPS (TTM) 0.86 PE Ratio 18.90 Exchange OTCPK
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3